Dalton Pharma Services is a Canadian CDMO and subsidiary of Seikagaku Corporation Japan, providing integrated drug discovery, development, and manufacturing services. The company is FDA-inspected and Health Canada-approved with over 35 years of experience, specializing in custom chemical synthesis, cGMP API manufacturing, sterile vial filling, and formulation development including liposomal formulations. Dalton recently announced major expansion of its commercial sterile manufacturing capacity.
Sterile vial filling, cGMP API manufacturing, custom synthesis, liposomal formulations, controlled drug manufacturing, accelerated stability testing
1 site worldwide
No reviews available yet.
No documents available.